PLASMA-DERIVATIVE

PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MATSUI HIROE, MIZUOCHI TSUGIO, CHITANI KOUICHI
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY COMPOSITIONS BASED THEREON DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC MACROMOLECULAR COMPOUNDS PHYSICS POLYSACCHARIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING THEIR PREPARATION OR CHEMICAL WORKING-UP
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE:To provide a plasma-derivative containing a clinically safe and well controlled plasma component. CONSTITUTION:The plasma derivative contains a plasma component substantially containing one kind of antigen selected from among a) type A sugar chain antigen and H (O) type sugar chain antigen, b) type B sugar chain antigen and H (O) type sugar chain antigen, c) type A sugar chain antigen, B type sugar chain antigen, and H (O) type sugar chain antigen, and H (O) type, and d) H (O) type sugar chain antigen as an effective component. In addition, the plasma derivative also contains a plasma component from which the A type and B type sugar chain antigens are removed as another effective component. Therefore, this plasma derivative is useful for the transfusion, etc., of a plasma- derived component at the time of treating patients suffering from hemophilia, vW disease, etc.